Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Discover the full record of transactions filed by Patusky Christopher, Consejero. Officer active across 1 company, notably UNITED THERAPEUTICS Corp. Aggregated, 32 reports have been recorded. Split: 1 buy · 4 sells. Total volume traded: €2.7m. Activity tracked since 6 May 2021. The latest transaction was disclosed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Patusky Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2000 títulos@ 88,03 US$0.0007% mcap8.5% de su flujoCommon StockSEC:0001415889-22-003051:0
25 de 32 declaraciones
About Patusky Christopher
PATUSKY CHRISTOPHER is Administrateur and a Director at UNITED THERAPEUTICS Corp, XNAS. He has 32 filings in total, and across the sampled recent filings from 2016-01-08 to 2026-07-13, purchases total 341 EUR and sales total 2654009 EUR, with the most frequent transaction nature shown as Levée d'options.